The PI3K/AKT/mTOR pathway is an intracellular signaling pathway important in regulating the cell cycle. Therefore, it is directly related to cellular quiescence, proliferation, cancer, and longevity. PI3K activation phosphorylates and activates AKT, localizing it in the plasma membrane. AKT can have a number of downstream effects such as activating CREB, inhibiting p27, localizing FOXO in the cytoplasm, activating PtdIns-3ps, and activating mTOR which can affect transcription of p70 or 4EBP1. There are many known factors that enhance the PI3K/AKT pathway including EGF, shh, IGF-1, insulin, and CaM. The pathway is antagonized by various factors including PTEN, GSK3B, and HB9. In many cancers, this pathway is overactive, thus reducing apoptosis and allowing proliferation. This pathway is necessary, however, to promote growth and proliferation over differentiation of adult stem cells, neural stem cells specifically. It is the difficulty in finding an appropriate amount of proliferation versus differentiation that researchers are trying to determine in order to utilize this balance in the development of various therapies.
BAY 11-7082是一种NF-κB抑制剂,抑制TNFα诱导的IκBα磷酸化,IC50为10 μM。
MoreIKK-16 (IKK Inhibitor VII)是一种选择性的IκB kinase(IKK)抑制剂,作用于IKK-2, IKK complex和IKK-1,IC50分别为40 nM, 70 nM和200 nM。
MoreIMD-0354是一种合成的选择性NF-kB 抑制剂。
MoreQNZ (EVP4593)有效抑制NF-κB激活和TNF-α产生,IC50分别为11 nM和7 nM。
MoreHonokiol, a low molecular weight natural product isolated from the bark of magnolia officinalis, possesses potent anticancer activities which is chiefly via the inhibition of AKT and mitogen-activated protein kinase (MAPK) phosphorylation. Honokiol是木兰的有效成分,抑制Akt磷酸化,且促进ERK1/2磷酸化。
More